Stobie; Alan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stobie; Alan.The latest application filed is for "morpholine compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions, and methods of use thereof".
Company Profile
0.17.28
- Stobie; Alan - Sandwich GB
- Stobie; Alan - Kent GB
- Stobie; Alan - US
- Stobie; Alan - County of Kent GB
- Stobie; Alan - Deal GB
- Stobie; Alan - Hambrook GB2
Patent Activity
| Patent | Date |
|---|---|
| Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof App 20100137316 - Fish; Paul Vincent ; et al. | 2010-06-03 |
| N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors App 20090239929 - Fish; Paul Vincent ; et al. | 2009-09-24 |
| N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors App 20090239928 - Fish; Paul Vincent ; et al. | 2009-09-24 |
| Novel Compounds App 20080306123 - Fish; Paul Vincent ; et al. | 2008-12-11 |
| Triazole derivatives which inhibit vasopressin antagonistic activity Grant 7,449,462 - Bryans , et al. November 11, 2 | 2008-11-11 |
| Triazole compounds useful in therapy Grant 7,442,795 - Bryans , et al. October 28, 2 | 2008-10-28 |
| Compounds Useful In Therapy App 20080188478 - Bryans; Justin Stephen ; et al. | 2008-08-07 |
| Novel Compounds App 20080161309 - Fish; Paul Vincent ; et al. | 2008-07-03 |
| Compounds Grant 7,378,436 - Fish , et al. May 27, 2 | 2008-05-27 |
| 3-Heterocyclyl-4-Phenyl-Triazole Derivatives as Inhibitors of the Vasopressin Via Receptor App 20070225333 - Bryans; JustinS ; et al. | 2007-09-27 |
| Triazole derivatives which inhibit vasopressin antagonistic activity App 20070203132 - Bryans; Justin S. ; et al. | 2007-08-30 |
| Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors App 20070105870 - Bish; Gerwyn ; et al. | 2007-05-10 |
| Phenyl heterocyclyl ethers Grant 7,129,234 - Adam , et al. October 31, 2 | 2006-10-31 |
| Amides useful as monoamine re-uptake inhibitors Grant 7,122,683 - Fish , et al. October 17, 2 | 2006-10-17 |
| Triazole compounds useful in therapy Grant 7,119,088 - Bryans , et al. October 10, 2 | 2006-10-10 |
| Triazole compounds useful in therapy App 20060194794 - Bryans; Justin Stephen ; et al. | 2006-08-31 |
| Lactams as tachykinin antagonists Grant 7,060,836 - Middleton , et al. June 13, 2 | 2006-06-13 |
| Novel compounds App 20060111429 - Fish; Paul Vincent ; et al. | 2006-05-25 |
| Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators Grant 6,979,690 - Gymer , et al. December 27, 2 | 2005-12-27 |
| Novel compounds App 20050250775 - Fish, Paul Vincent ; et al. | 2005-11-10 |
| Quinazolinone compounds useful in therapy Grant 6,936,619 - Blagg , et al. August 30, 2 | 2005-08-30 |
| Novel compounds App 20050137229 - Fish, Paul Vincent ; et al. | 2005-06-23 |
| N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase Grant 6,849,649 - Challenger , et al. February 1, 2 | 2005-02-01 |
| Triazole compounds useful in therapy App 20040186091 - Bryans, Justin Stephen ; et al. | 2004-09-23 |
| Lactams as tachkinin antagonists App 20040132710 - Middleton, Donald Stuart ; et al. | 2004-07-08 |
| Phenyl heterocyclyl ethers App 20040106594 - Adam, Mavis D. ; et al. | 2004-06-03 |
| N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase App 20040106611 - Challenger, Stephen ; et al. | 2004-06-03 |
| Imidazopyridine compounds as 5-HT4 receptor modulators App 20040034226 - Uchida, Chikara ; et al. | 2004-02-19 |
| Compounds useful in therapy App 20040029859 - Blagg, Julian ; et al. | 2004-02-12 |
| N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase Grant 6,660,756 - Challenger , et al. December 9, 2 | 2003-12-09 |
| Phenyl heterocyclyl ethers App 20030207857 - Adam, Mavis D. ; et al. | 2003-11-06 |
| Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators App 20030207875 - Gymer, Geoffrey ; et al. | 2003-11-06 |
| Phenoxyphenylheterocyclyl derivatives as SSRIs Grant 6,630,504 - Andrews , et al. October 7, 2 | 2003-10-07 |
| Imidazopyridine compounds as 5-HT4 receptor modulators Grant 6,624,162 - Uchida , et al. September 23, 2 | 2003-09-23 |
| Phenoxybenzylamine derivatives as SSRIs Grant 6,610,747 - Adam , et al. August 26, 2 | 2003-08-26 |
| Alkylamide compounds App 20030105097 - Simon, Andrew ; et al. | 2003-06-05 |
| N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase App 20030105132 - Challenger, Stephen ; et al. | 2003-06-05 |
| Imidazopyridine compounds as 5-HT4 receptor modulators App 20030092699 - Uchida, Chikara ; et al. | 2003-05-15 |
| Phenoxybenzylamine derivatives as SSRls App 20030060456 - Adam, Mavis Diane ; et al. | 2003-03-27 |
| Phenoxyphenylheterocyclyl derivatives as SSRIs App 20020183303 - Andrews, Mark David ; et al. | 2002-12-05 |
| Diphenyl ether compounds useful in therapy App 20020052395 - Andrews, Mark David ; et al. | 2002-05-02 |
| Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase App 20020052370 - Barber, Christopher Gordon ; et al. | 2002-05-02 |
| Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them Grant 5,543,419 - Cross , et al. August 6, 1 | 1996-08-06 |
| Antimuscarinic bronchodilators Grant 5,171,744 - Cross , et al. December 15, 1 | 1992-12-15 |
| Dihydropyridines and use thereof in treating hypertension and ischaemia Grant 4,806,557 - Campbell , et al. February 21, 1 | 1989-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 